← Leaderboards
Jessica Lynn Fessler
University Of Chicago
$474,631
Attributed
$474,631
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $102.2K · FY2018–24$200K$150K$100K$50K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$474,631 · 2
By mechanism
K00$383,591 · 1
F99$91,040 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Chicago
Same institution · by research overlap
- Derek Alan Wainwright$7,505,477
- Erika C Claud$12,656,656
- Michael Rust$3,379,306
- Ezra Cohen$7,350,375
- Anna Birukova$12,956,677
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectCommensal BacteriaAnti-CancerAnti-Pd-L1CohortAnti-Tumor Immune ResponseBacteriaBacterial GenesBacterial GenomeBacterial ModelAntibodiesAdjuvantBifidobacteriumBioinformaticsCancer ImmunotherapyCancer PatientCancer TherapyCd8-Positive T-LymphocytesCell PhysiologyCellsCell TypeClinicClinical DataComputational Biology
Grant awards (6)
Leveraging gnotobiotic models to study the gut microbiota and anti-tumor immunity$102,181
K00 · FY2024 · CA · contact PI
Leveraging gnotobiotic models to study the gut microbiota and anti-tumor immunity$97,722
K00 · FY2023 · CA · contact PI
Leveraging gnotobiotic models to study the gut microbiota and anti-tumor immunity$93,263
K00 · FY2022 · CA · contact PI
Leveraging gnotobiotic models to study the gut microbiota and anti-tumor immunity$90,425
K00 · FY2021 · CA · contact PI
Identifying mechanisms of microbiota-dependent anti-tumor immune modulation and metabolically manipulating bacteria to improve treatment efficacy$45,016
F99 · FY2019 · CA · contact PI
Identifying mechanisms of microbiota-dependent anti-tumor immune modulation and metabolically manipulating bacteria to improve treatment efficacy$46,024
F99 · FY2018 · CA · contact PI